Amgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and Eli Lilly lower.
Source: https://www.cnbc.com/2024/05/03/amgen-s ... slide.html
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
